GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2051 - 2075** of **4050** in total

« First

‹ Prev

…

79

80

81

82

83

84

85

86

87

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgA	Patient 3	-180	mild	G86541PE	246
IgG	Patient 3	-180	mild	G15407YE	246
IgM	Patient 3	11	mild	G66937TJ	246
IgM	Patient 4	12	mild	G47566FL	244
IgM	Patient 4	12	mild	G67045LB	244
IgG	Patient 1	22	moderate	G49108TO	243
IgA	Patient 2	15	mild	G78074HX	243
IgA	Patient 2	24	mild	G00054MO	243
IgM	Patient 2	24	mild	G25407RZ	243
IgA	Patient 1	6	moderate	G68461PT	242
IgM	Patient 2	3	mild	G21460SG	242
IgG	Patient 3	4	mild	G42666HT	242
IgM	Patient 2	24	mild	G36191CD	241
IgA	Patient 2	3	mild	G78074HX	241
IgM	Patient 2	3	mild	G10789DJ	241
IgM	Patient 1	22	moderate	G58969RU	240
IgM	Patient 2	15	mild	G39213VZ	240
IgA	Patient 2	3	mild	G02557XE	240
IgM	Patient 1	22	moderate	G09609EN	239
IgA	Patient 3	-180	mild	G21320TF	239
IgG	Patient 1	10	moderate	G49108TO	238
IgM	Patient 2	24	mild	G19118WX	238
IgM	Patient 2	3	mild	G62222PE	238
IgA	Patient 3	-180	mild	G00054MO	238
IgA	Patient 3	-180	mild	G54064FW	238